Loading...
Combined γ‐tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial‐to‐mesenchymal transition and migration
OBJECTIVES: Dysregulation of Met signalling is associated with malignant transformation. Combined treatment has been shown to reduce Met activation and mammary tumour cell proliferation. Experiments here, were conducted to determine mechanisms involved in mediating anti‐cancer effects of combined γ‐...
Na minha lista:
| Udgivet i: | Cell Prolif |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6495965/ https://ncbi.nlm.nih.gov/pubmed/24033536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12059 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|